Hao Zeng
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis 4
-
- Cancer, Hypoxia, and Metabolism 2
- Cancer, Lipids, and Metabolism 2
-
- Pancreatic and Hepatic Oncology Research 2
-
- Ferroptosis and cancer prognosis 3
-
- Liver Disease Diagnosis and Treatment 3
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 3
-
- Nutrition and Health in Aging 3
- Co-authors
- Yunwei HanHongwei ZhangJing WangLu GuoKe SuTao GuKe XuKun He
- Cited by
- HepatologyCancer ResearchOncology
- Partner nations
- ChinaUnited KingdomRussia
In The Last Decade
Hao Zeng
18 papers receiving 203 citations
Peers
Comparison fields: 5 of 53
- Hepatology 54
- Cancer Research 51
- Oncology 60
- Immunology 36
- Pulmonary and Respiratory Medicine 42
Countries citing papers authored by Hao Zeng
This map shows the geographic impact of Hao Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Zeng more than expected).
Fields of papers citing papers by Hao Zeng
This network shows the impact of papers produced by Hao Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Zeng. The network helps show where Hao Zeng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hao Zeng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 9 | |
| 9 | 2024 | 5 | |
| 10 | 2023 | 30 | |
| 11 | 2023 | 3 | |
| 12 | 2023 | 20 | |
| 13 | 2023 | 24 | |
| 14 | 2023 | 3 | |
| 15 | 2023 | 7 | |
| 16 | 2022 | 14 | |
| 17 | 2022 | 0 | |
| 18 | 2022 | 30 | |
| 19 | 2022 | 2 | |
| 20 | 2021 | 43 |
About Hao Zeng
Hao Zeng is a scholar working on Hepatology, Cancer Research and Geriatrics and Gerontology, having authored 20 papers that have together received 206 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Liver Disease Diagnosis and Treatment (3 papers), Ferroptosis and cancer prognosis (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Nutrition and Health in Aging (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Cancer, Lipids, and Metabolism (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Hepatology (54 citations), Cancer Research (51 citations) and Oncology (60 citations). Hao Zeng has collaborated with scholars based in China, United Kingdom and Russia. Frequent co-authors include Yunwei Han, Hongwei Zhang, Jing Wang, Lu Guo, Ke Su, Tao Gu, Ke Xu, Yunwei Han, Kun He and Yunwei Han. Their work appears in journals such as Scientific Reports, Frontiers in Microbiology and BMC Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.